Search all trials

Find therapies in clinical trials near you – page 14

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Clostridium difficile infection

Recruiting

Investigational

Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

Investigational

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live

Contact Research Centre

Neoplasm+1

Recruiting

InvestigationalNo placebo

Study of NVL-655 for Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors with ALK Mutation

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nvl-655

Contact Research Centre

Lymphoma+4

Recruiting

InvestigationalNo placebo

Study of OSE-279 and OSE2101 Drug Combination for Patients with Advanced Solid Tumors, Lymphomas, or Metastatic Non-Small Cell Lung Cancer

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Imsidolimab

Contact Research Centre

Rectal cancer

Recruiting

Registered drugNo placebo

Study of Durvalumab with Drug Combination for Patients with Locally Advanced Rectal Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Calcium Folinate

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drug

Study of Pembrolizumab and V940 for Treating Non-Small Cell Lung Cancer in Patients with Resectable Stage II to IIIB (N2) Not Achieving Complete Response

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Breast cancer+1

Recruiting

Registered drugNo placebo

Study on Zanidatamab and Chemotherapy for Patients with Metastatic HER2-Positive Breast Cancer After Trastuzumab Deruxtecan Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Cerebral haemorrhage

Recruiting

Registered drugNo placebo

Study on the Effects of Continuing or Stopping Simvastatin and Atorvastatin in Patients with Spontaneous Lobar Intracerebral Hemorrhage

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Atorvastatin

Contact Research Centre

Myocarditis+2

Recruiting

Registered drug

Study on the Use of Methylprednisolone Sodium Succinate for Treating Patients with Acute Myocarditis and Mildly Reduced Heart Function

Registered drug

Spain

Participants:18–64 years
Substances:Sodium Chloride

Contact Research Centre

Colorectal cancer metastatic

Recruiting

Registered drugNo placebo

Study on Bevacizumab, Encorafenib, and Cetuximab for Patients with BRAF-V600E Mutated Metastatic Colorectal Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Lung neoplasm malignant+2

Recruiting

Registered drugNo placebo

Study on Niraparib with Immunotherapy for Patients with SLFN11-Positive Extensive-Stage Small Cell Lung Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Colorectal cancer+5

Recruiting

InvestigationalNo placebo

Study on Long-Term Safety of Trastuzumab Deruxtecan for Patients with Advanced HER2-Positive or HER2-Mutated Solid Tumors

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Trastuzumab Deruxtecan

Contact Research Centre

Psoriatic arthropathy

Recruiting

Investigational

Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis Who Have Not Responded Well to Previous Biologic Treatments

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Find therapies in clinical trials near you – page 14

575 trials match your criteria

Clostridium difficile infection

Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

Neoplasm+1

Study of NVL-655 for Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors with ALK Mutation

Lymphoma+4

Study of OSE-279 and OSE2101 Drug Combination for Patients with Advanced Solid Tumors, Lymphomas, or Metastatic Non-Small Cell Lung Cancer

Rectal cancer

Study of Durvalumab with Drug Combination for Patients with Locally Advanced Rectal Cancer

Non-small cell lung cancer

Study of Pembrolizumab and V940 for Treating Non-Small Cell Lung Cancer in Patients with Resectable Stage II to IIIB (N2) Not Achieving Complete Response

Breast cancer+1

Study on Zanidatamab and Chemotherapy for Patients with Metastatic HER2-Positive Breast Cancer After Trastuzumab Deruxtecan Treatment

Cerebral haemorrhage

Study on the Effects of Continuing or Stopping Simvastatin and Atorvastatin in Patients with Spontaneous Lobar Intracerebral Hemorrhage

Myocarditis+2

Study on the Use of Methylprednisolone Sodium Succinate for Treating Patients with Acute Myocarditis and Mildly Reduced Heart Function

Colorectal cancer metastatic

Study on Bevacizumab, Encorafenib, and Cetuximab for Patients with BRAF-V600E Mutated Metastatic Colorectal Cancer

Lung neoplasm malignant+2

Study on Niraparib with Immunotherapy for Patients with SLFN11-Positive Extensive-Stage Small Cell Lung Cancer

Colorectal cancer+5

Study on Long-Term Safety of Trastuzumab Deruxtecan for Patients with Advanced HER2-Positive or HER2-Mutated Solid Tumors

Psoriatic arthropathy

Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis Who Have Not Responded Well to Previous Biologic Treatments

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.